Clinical Trials Logo

Clinical Trial Summary

The investigators will evaluate the efficacy of soy dietary fiber in adults with diarrhea predominant irritable bowel syndrome.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01373034
Study type Interventional
Source Seoul National University Hospital
Contact Joo Sung Kim, M.D., PhD
Phone +82-2-740-8112
Email jooskim@snu.ac.kr
Status Not yet recruiting
Phase N/A
Start date July 2011
Completion date July 2012

See also
  Status Clinical Trial Phase
Terminated NCT02239926 - Effect of Ranolazine on Gastrointestinal Motor Function and Pain in Patients With IBS-D Phase 2/Phase 3
Completed NCT02251483 - Use of SBI in IBS Subjects Following a Successful Treatment of Small Intestinal Bacterial Overgrowth N/A
Completed NCT01896583 - A Phase 2 Pilot Study to Assess ASP7147 in Patients With Diarrhea Predominant Irritable Bowel Syndrome (IBS-D) Phase 2
Completed NCT01100684 - Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) Phase 3
Completed NCT02728063 - Lactibiane Tolérance® in Individuals Suffering From Irritable Bowel Syndrome With Diarrheal Predominance N/A
Completed NCT02358694 - Safety and Tolerability of Serum Derived Bovine Immunoglobulin in Children With Diarrhea Predominant IBS N/A
Recruiting NCT01637714 - The Effects of Multi-strain Probiotics in Adults With Diarrhea Predominant Irritable Bowel Syndrome N/A
Completed NCT01094041 - Gluten Intolerance in Patients With Diarrhea Predominant Irritable Bowel Syndrome N/A
Completed NCT00616200 - Effects of a Very Low Carbohydrate Diet on Symptoms of Irritable Bowel Syndrome (IBS) N/A
Completed NCT02111603 - Ability of Mayo Clinic High-performance Liquid Chromatography (HPLC) Method to Measure Fecal Bile Acids Phase 4